Concord Drugs Market Cap

Concord Drugs has a market cap or net worth of 1.01 billion as of March 10, 2026. Its market cap has increased by 209.68% in one year.

Market Cap

1.01B

Enterprise Value

1.20B

Revenue

512.41M

Ranking

n/a

PE Ratio

169.19

Stock Price

76.91

Market Cap Chart

Since February 23, 2015, Concord Drugs's market cap has increased from 144.80M to 1.01B, an increase of 599.77%. That is a compound annual growth rate of 19.26%.

Market Cap History

Date	Market Cap	% Change
Mar 9, 2026	977.59M	-10.04%
Dec 31, 2025	1.09B	188.24%
Dec 31, 2024	377.00M	-36.87%
Dec 29, 2023	597.20M	109.83%
Dec 30, 2022	284.61M	1.24%
Dec 31, 2021	281.11M	40.39%
Dec 31, 2020	Pro	Pro
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Mercury Laboratories	951.12M
Makers Laboratories	849.65M
Lactose (India)	1.15B
Bal Pharma	1.15B
Pharmaids Pharmaceuticals	1.21B
Source Natural Foods and Herbal Supplements	794.00M
Accretion Pharmaceuticals	730.32M
Amwill Health Care	717.13M

Market Cap Rankings